In vitro diagnostics

Contributing to human health with innovative technology.

Last News

Medriva COVID-19
rapid antigen test kit

Easy to use. No PCR lab need
Simple operation, no equipment required

Self-test available in
a lot of countries

Europe, Asia & Latin America

Austria, Belgium, Brunei, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Honduras, Hong Kong, Hungary, Iceland, Ireland, Italy, Lithuania, Malaysia, Netherlands, Norway, Poland, Romania, Spain, Latvia, Sweden, Switzerland, Thailand and Ukraine.

Hong Kong

Medriva COVID-19 Rapid Antigen Test is now available to order online, at your local Mannings, HKTVMall, and are purchased by the Hong Kong Government.

IN PROCESS

Finland, Greece, Indonesia, Liechtenstein, Luxembourg, Malta, New Zealand, Portugal, Singapore, Slovakia, Slovenia, South Africa, Vietnam

SARS-CoV-2 rapid
antigen self tests

Moving On

A Path Forward

Now, with Medriva authorized for over the counter for frequent asymptomatic use, we are making testing directly available for when and where you need it. You can now access our Medriva test in three ways: at your local retailer, order online directly or ask your healthcare professional.

Mass rapid testing (MRT) the new path forward?

As countries begin to live with COVID-19, mass rapid testing (MRT) becomes the main tool to control any future outbreaks. Eliminating the virus completely, through stringent lockdown and quarantine measures, and treating it as endemic are often discussed as mutually exclusive strategies. Frequent and widespread adoption of at-home antigen rapid testing could offer the best of both worlds.

Aren`t PCR tests the gold standard?

Aren’t PCR Tests the Gold Standard? Critics of RATs say that PCR is much more sensitive, but this can actually be a liability when it detects a residual amount of RNA during a waning, non-infectious case. Data from a study by the UK COVID-19 Lateral Flow Oversight Team shows that RAT sensitivity for contagious cases, even when asymptomatic, is typically around 97 percent. This means that, with rapid testing, positive individuals can reliably know which few days they need to stay at home, while everyone else testing negative can confidently get on with their lives.

Investing in R&D for a brighter tomorrow

Medriva is a professional in-vitro diagnostics company with aims of contributing to higher life quality by diagnosing illnesses accurately and quickly. Guarding human lives is the most vital component of the healthcare system during this pandemic situation. The most pressing need is to have access to precise diagnostic processes in order to get primary treatment. Because of this, Medriva has invested millions of dollars in R&D to bring new COVID-19 diagnostics kits and tests to the market across Asia, Australia, Europe and North America.

Medriva is built on protection

We strive to achieve patient health. And we’ll get there using innovation, product development, and the most advanced R&D team.

We strive to achieve patient health. And we’ll get
there using innovation, product development, and
the most advanced R&D team.

Medriva

Sign in

Register